Abstract:Background Although hepatectomy is often performed with the Pringle maneuver, the problem of hepatic ischemia-reperfusion injury (HIRI) can also be serious. Thus, the present study was designed to investigate the protective effect of S-adenosylmethionine (SAMe) on HIRI, especially for patients with hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) infection and cirrhosis. Methods Eighty-one HCC patients with chronic HBV infection, undergoing partial hepatectomy with inflow occlusion, were divided into three groups. In the pretreatment group (PR group, n = 26), patients were given SAMe two hours before surgery. In the post-treatment group (PO group, n = 25), patients were given SAMe six hours after surgery. And in the control group (control group, n = 30), patients received partial hepatectomy without any SAMe. All pre-, intra- and postoperative blood samples were collected to measure the plasma levels of transaminases, bilirubin and cytokines. The results were compared among the three groups. Results There were no statistically significant intergroup differences observed in age, gender, hepatic inflow occlusion time and the results of liver function tests. Preoperative administration of SAMe (PR group) significantly reduced the plasma levels of alanine transaminase (ALT), aspartate transferase (AST), total bilirubin (TBIL) and direct bilirubin (DBIL) as compared to the other two groups. In the PO group, TBIL and DBIL were significantly lower than in the control group. Significant differences were also seen in IL-6 and TNF-α between the PR group and the other groups. In all groups, postoperative liver reserve function in the PR group as revealed by ICGR15 (Post ICGR15) was at its best before abdominal closure. Compared to the control group, the risk of complications and the hospital stay after surgery were significantly meliorated in the PR group. Additionally, patients with cirrhosis had a more acute rate of change in ALT and AST than non-cirrhotic patients. Conclusions Taken together, our preliminary findings suggest that preoperative administration of SAMe is useful and safe for reducing the HIRI in partial hepatectomy, especially for HCC patients whose disease is associated with chronic HBV infection and cirrhosis.

Clinical effect of S-adenosylmethionine on patients with hepatocellular carcinoma resection

Protective Effects of S-adenosylmethionine on Liver Function in HCC Patients after Liver Resection

The effect of intraoperative administration of S-adenosy-methionine on remnant liver function and regeneration after left lobe resection

Beneficial Effects of S-adenosyl-L-methionine on Post-Hepatectomy Residual Liver Function: a Prospective, Randomized, Controlled Clinical Trial.

Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection

The Effect of S-adenomethionine on Early Stage Recovery of Transplanted Liver Function

PROTECTIVE EFFECTS OF S-ADENOSYL-L-METHIONINE ON POST-HEPATECTOMY LIVER FUNCTION

Prospective, randomized and controlled trial study on protective effects of S-adenosylmethionine (enteric-coated tablets) on liver function after transcatheter arterial chemoembolization (TACE)

Clinical study of S-adenosyl-L-methionine in the treatment of malignant obstructive jaundice after surgical drainage

Effect of Preoperative Hepatic and Regional Arterial Chemotherapy on Metachronous Liver Metastasis after Curative Colorectal Cancer Resection: A Prospective, Multicenter, Randomized Controlled Trial

Effect of Hepatitis on Surgical Treatment and Prognosis of Colorectal Liver Metastasis

Effect of adenosylmethionine in Treatment of Alcoholic cirrhosis

Therapeutic effect of adenosylmethionine on viral hepatitis and related factors inducing diseas

Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-term Survival and Recurrence in Patients with Resectable Huge Hepatocelluar Carcinoma A Multicentre Retrospective Analysis

Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients.

Hepatic Histopathology and Postoperative Outcome after Preoperative Chemotherapy for Chinese Patients with Colorectal Liver Metastases.

Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: a Single Center Analysis.

Effect of Preoperative Transcatheter Arterial Chemoembolization for Treatment of Resectable Large Hepatocellular Carcinoma:A Clinical Randomized Controlled Trial

Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta‐analysis.

The treatment effect of ursodeoxycholic acid combined with S-adenosyl-L-methionine on drug-induced cholestatic liver injury

Effect of Postoperative Adjuvant Chemotherapy on Prognosis of Patients with Hilar Cholangiocarcinoma after Surgical Resection